FY26 underlying EBITDA met guidance, while revenue was slightly below expectations due to revenue recognition changes, with strong 2H26 cashflow. FY27 will focus on organic growth, with major investments in AI, ERP, and Scholarion TM, and a one-off goodwill impairment of $20–25 million.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.